Enter your login e-mail to the account
Search
Search parameters
Search results
- Sekundární dyslipoproteinémie
MUDr. Michal Vrablík, PhD., doc. MUDr. Richard Češka, CSc.
(1/2004, Main topic ) - Současnost a perspektivy léčby dyslipidémií
doc. MUDr. Jan Bultas, CSc., MUDr. Debora Karetová
(1/2004, Main topic ) - Epidemiologic situation in Slovakia – circulation disorders and their risk factors
MUDr. Anna Baráková
(1/2009, Topic of the year ) - Investigation of the obese patient in clinical practice
doc. MUDr. Boris Krahulec, CSc.
(2/2015, Topic of the year ) - Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - Chyby a úskalí terapie statiny
MUDr. Lubor Goláň
(1/2004, Main topic ) - SECONDARY PREVENTION IN ACUTE MYOCARDIAL INFARCTION
MUDr. Branislav Tomašovič, MUDr. Marián Kozlovský
(1/2006, Topic ) - Classification of dyslipoproteinaemias: Part II – Secondary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(6/2009, Topic of the year ) - Podľa medzinárodnej akademickej nadácie R3i prináša ACCORD Lipid novú nádej diabetikom 2. typu s aterogénnou dyslipidémiou
MUDr. Ľubomíra Fábryová, PhD.
(2/2010, Topic of the year ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Prehľad aktuálnych európskych (ESH/ESC 2003) a amerických (JNC 7) odporúčaní pre liečbu hypertenzie
MUDr. Jozef Bulas, CSc.
(3/2004, Topic ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - The Importance of Omega – 3 Fatty Acids in the Treatment of Dyslipidemia
prof. MUDr. Daniel Pella, PhD.
(12/2009, Topic of the year ) - Komentár k odporúčaniam ACC/AHA (ACC/AHA Guidelines on the Treatment of Blood Cholesterol)
MUDr. Ľubomíra Fábryová, PhD., prof. MUDr. Andrej Dukát, CSc., FESC
(2/2014, Information & comments ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - CLIMACTERIC AND THE CARDIOVASCULAR SYSTEM
MUDr. Ján Števlík
(6/2006, Main topic ) - NOVÉ TRENDY V PREVENCII ATEROSKLERÓZY
(3/2007, Events ) - Etiopathogenesis of atherosclerosis
MUDr. Ľubomíra Fábryová, PhD.
(2/2009, Topic of the year ) - TREATMENT OF ARTERIAL HYPERTENSION IN ELDERLY PEOPLE AND IN DEMENTIA PREVENTION
prof. MUDr. Zoltán Mikeš, DrSc.
(7-8/2006, Main topic ) - Správa zo XIV. slovenských obezitologických dní s medzinárodnou účasťou
MUC. Michal Pečík
(5/2016, Events ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Správa zo XVI. európskeho kongresu o hypertenzii.
doc. MUDr. Marian Sninčák, CSc.
(7-8/2006, Events ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - The review of clinical and preclinical studies about the effects of Chlorella pyrenoidosa and young barley leaves on organism
doc. MUDr. Martin Péč, PhD., doc. MUDr. Renata Péčová, PhD., Doc. RNDr. Peter Kubatka, PhD.
(5/2015, Review articles ) - Reach target LDL cholesterol more effective dose of atorvastatin 30 mg in the practice of general practitioners
MUDr. Martin Čaprnda, PhD., MUDr. Ján Hencel, MSc., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2015, Original articles & case reports ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Pharmacological therapy and non-pharmacological measures in patient after myocardial infarction
prof. MUDr. Peter Mitro, PhD.
(2/2011, Review articles ) - Risk factors of atherosclerosis: lipids and their relation to atherosclerosis
MUDr. Branislav Vohnout, PhD., doc. MUDr. Katarína Rašlová, CSc.
(3/2009, Topic of the year ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - Metabolické ochorenia – čoraz väčšia výzva pre výskum i klinickú prax
MUDr. Fábryová Ľubomíra, PhD.
(5/2012, Editorial ) - Promoting prevention and treatment of cardiovascular disease through nutrition supplements
doc. MUDr. Štefan Farský, CSc., FESC
(5/2012, Review articles ) - AtheroEDUC 2009 – projekt Slovenskej Asociácie Aterosklerózy a časopisu Via Practica
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2009, Editorial ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - Physical exercise – mandatory part of complex dyslipidemia managment
prof. MUDr. Dušan Meško, PhD.
(7-8/2009, Topic of the year ) - DIABETIC DYSLIPIDAEMIA – IMPORTANT PART OF THE COMPLEX CARE FOR THE PATIENTS WITH DIABETES TYPE 2
MUDr. Ľubomíra Fábryová
(1/2005, Topic ) - Retardované mononitráty v klinické praxi
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Spectrum ) - PREVENTION OF CARDIOVASCULAR DISEASES IN POSTMENOPAUSAL WOMEN
prof. MUDr. Miroslav Borovský, CSc., MUDr. Michaela Lattáková, PhD.
(4-5/2008, Topic ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - Determination of high-sensitivity CRP as a predictor of cardiovascular risk in terms of general practice for adults
MUDr. Jana Bendová
(3-4/2014, General Medicine ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
prof. MUDr. Daniel Pella, PhD., doc. MUDr. Viola Mechírová, CSc.
(S4/2007, Supplement ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Pán doktor, príďte! Zápisky lekára po 100 rokoch
MUDr. Jozef Jakuš
(4/2005, Relax ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - MANAGEMENT OF PATIENTS AFTER CORONARY REVASCULARISATION PROCEDURES: GENERAL PRACTITIONER`S
prof. MUDr. Vasiľ Hricák, PhD., MFSC.
(4/2005, Topic ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - ALCOHOL AND DIABETES MELLITUS
MUDr. Jiří Mudra, doc. MUDr. Zdeněk Rušavý
(1/2005, Topic ) - POSSIBILITIES OF DIAGNOSIS AND TREATMENT OF LIPIDS DISORDERS IN AMBULANCE OF GENERAL PRACTITIONER
MUDr. Ľubomíra Fábryová
(6/2005, clearly ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - LONGTERM CARE AFTER ACUTE CORONARY SYNDROME WITHOUT ELEVATION OF ST-SEGMENT IN PRACTITIONER`S OFFICE
MUDr. Eva Baranová
(5/2007, Topic ) - Hypolipidemic treatment and target values of lipids
MUDr. Ondřej Kyselák, prof. MUDr. Vladimír Soška, CSc.
(1/2019, Review articles ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - Ezetimibe in the treatment of hypercholesterolaemia
doc. MUDr. David Karásek, Ph.D.
(3/2020, Review articles ) - PREVENTION OF THE ISCHEMIC HEART DISEASE
MUDr. Milan Luknár, MUDr. Branislav Líška
(4/2005, Topic ) - Care for patients after myocardial revascularization therapy in general practitioner`s office
Prof. MUDr. Vasiľ Hricák, PhD., FESC
(6/2016, Review articles ) - Epidemiology and health consequences of obesity
MUDr. Ľubomíra Fábryová, PhD.
(1/2015, Topic of the year ) - Statins and acute coronary syndrome
prof. MUDr. Ján Murín, CSc.
(1/2010, Review articles ) - Molecular genetics of dyslipidemy
Ing. Jaroslav A. Hubáček, CSc., MUDr. Michal Vrablík, PhD.
(4/2009, Topic of the year ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - Drug-induced myopathy with cholesterol-lowering and triacylglycerol-lowering agents
doc. MUDr. Peter Špalek, CSc., MUDr. Denis Richter
(1/2010, Interdisciplinary consilium ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Srovnání účinnosti semi-generického a originálního atorvastatinu
doc. MUDr. Richard Češka, CSc., prof. MUDr. Helena Vaverková, CSc., as. MUDr. Michal Vrablík, PhD., Jitka Housová, Tomáš Štulc, Željko Reiner, Zvonimir Rumboldt
(5/2005, Spectrum ) - Pilotný projekt vyhľadávania závažných dyslipoproteinémií v slovenskej populácii 40-ročných – dizajn štúdie
MUDr. Ľubomíra Fábryová, doc. MUDr. Rašlová Katarína, CSc.
(2/2004, Focus ) - Stretnutie odborníkov s členmi Spoločnosti familiárnych hyperlipoproteinémií
MUDr. Ľubomíra Fábryová, PhD., MUDr. Eva Rajecová, doc. MUDr. Jana Sirotiaková, CSc.
(1/2010, Events ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - The role of diet therapy in complex treatment of dyslipoproteinemias
MUDr. Viera Kissová, PhD.
(9/2009, Topic of the year ) - New options in diagnostics and treatment of familial hypercholesterolemia
MUDr. Šárka Tesařová, Prof. MUDr. Michal Vrablík, Ph.D.
(3/2019, Review articles ) - XIV. medzinárodné sympózium o ateroskleróze v Ríme
MUDr. Ľubomíra Fábryová
(9/2006, Events ) - Poškodenie pečene alkoholom a liekmi
doc. MUDr. Peter Jarčuška, PhD., MUDr. Mária Zakuciová, MUDr. Eduard Veseliny
(10/2006, clearly ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - IDEA – THE FIRST RESULTS ABOUT PREVALENCE OF ABDOMINAL OBESITY IN SLOVAKIA
prof. MUDr. Andrej Dukát, CSC., FESC, doc. MUDr. Ján Lietava, CSc., doc. MUDr. Boris Krahulec, CSc., doc. MUDr. Jozef Glasa, CSc., MUDr. Viera Kosmálová
(12/2006, Topic ) - CONGESTIVE HEART FAILURE TREATMENT
prof. MUDr. Viliam Bada, CSc.
(11/2007, Topic ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - Svetový deň srdca 2009 aj s účasťou všeobecných lekárov
redakcia Solen
(10/2009, Focus ) - CHRONIC ISCHEMIC HEART DISEASE – STABLE ANGINA: CURRENT DIAGNOSTIC AND TREATMENT POSSIBILITIES
MUDr. Stanislav Juhás, CSc.
(11/2007, Topic ) - Prediabetes
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mim. prof.
(1/2017, Review articles ) - ACUTE MYOCARDIAL INFARCTION: ACTUAL MANAGMENT PRINCIPLES
I. interná klinika MFN, Martin
(11/2007, Topic ) - OBESITY AND SPORT ACTIVITY
prof. MUDr. Dušan Meško, PhD.
(11/2007, Spectrum ) - Classification of dyslipoproteinaemias: Part I – Primary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(5/2009, Topic of the year ) - Pharmacotherapy of stable angina pectoris – current review
MUDr. Anna Vachulová, PhD., MUDr. Mgr. Zuzana Lovásová, MUDr. Martina Kováčová, MUDr. Kristína Letková
(1/2011, Review articles ) - News in ESC/EAS recommendations 2019 for dyslipidemia management
MUDr. Ľubomíra Fábryová, PhD.
(6/2019, Review articles ) - THE EPIDEMIOLOGY OF OVERWIGHT AND OBESITY IN SLOVAKIA
doc. MUDr. Boris Krahulec, CSc., prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ján Lietava, CSc., MUDr. Milan Luliak, PhD., MUDr. Martin Čaprnda, PhD., MUDr. Ivar Vacula, PhD.
(3/2008, Topic ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic ) - POSSIBILITIES OF USING OF FOOD SUPPLEMENTS IN TREATMENT OF PATIENTS WITH OVERwEIGHT AND OBESITY
PharmDr. Peter Stanko
(3/2008, clearly )
- METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - The effect of antidepressants on serum lipid parameters
MUDr. Dagmar Breznoščáková, Mgr. Martina Chylová, PhD., Klára Maceková
(4/2011, Original articles & case reports ) - ADHD – možnosti alternatívnej terapie
MUDr. Jana Trebatická, PhD., Doc. MUDr. Igor Škodáček, CSc.
(2/2018, Review articles ) - Effect of a combined psychotherapeutic and psychopharmacologic treatment on a long-term glycemic control in diabetes mellitus type 1 and 2. A retrospective study
MUDr. Jana Komorousová, MUDr. Zdeněk Jankovec, Ph.D., MUDr. Jiří Podlipný, Ph.D.
(4/2016, online attachment ) - Aging of a woman and hormonal replacement therapy
prof. MUDr. Jaroslav Živný, DrSc.
(6/2004, Review articles ) - Atypical antipsychotics and diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(1/2013, Review articles ) - INVEGA – PALIPERIDON ER TABLETY S PRODLOUŽENÝM UVOLŇOVÁNÍM
MUDr. Ivan Tůma, CSc.
(6/2008, Psychopharmacology ) - PRAKTICKÉ TIPY PRO SLEDOVÁNÍ BEZPEČNOSTI PŘI DLOUHODOBÉ LÉČBĚ ANTIPSYCHOTIKY
MUDr. Jiří Masopust
(4/2007, In short ) - Prevention of cardiovascular risk and diabetes in schizophrenia patients: application of internet in clinical praxis
MUDr. Jiří Masopust, Ph.D., MUDr. Radovan Malý, Ph.D.
(5–6/2010, In short ) - Safety monitoring of the treatment with risperidone in children and adolescents
prof. MUDr. Ivana Drtílková, CSc.
(2/2016, Digital publications ) - Ziprasidone treatment and metabolic parameters changes
MUDr. Jozef Dragašek, PhD., MUDr. Simona Líšková
(2/2011, Original articles & case reports ) - Influence of antidepressant on body weight
prof. MUDr. Eva Češková, CSc.
(5/2009, Review articles ) - LONG-TERM TREATMENT OF SCHIZOPHRENIA
MUDr. Klára Látalová, Ph.D., doc. MUDr. Vladimír Pidrman, Ph.D.
(4/2006, Review articles )
- Komorbidita a cievne mozgové príhody
doc. MUDr. Zuzana Gdovinová, CSc.
(5/2005, Main topic ) - Statins and myopathy
prof. MUDr. Zdeněk Ambler, DrSc. †
(6/2013, Review articles ) - Idiopatická ľahká kognitívna dysfunkcia
doc. MUDr. Egon Kurča, PhD.
(1/2004, Main topic ) - Neurologické projevy poruch metabolizmu lipidů
doc. MUDr. Ivanka Vlachová
(1/2005, Main topic ) - Diabetická polyneuropatia
MUDr. Gabriel Hajaš, PhD.
(3/2018, Main topic ) - Binswangerova choroba – subakutní vaskulární demence
MUDr. Michal Bar
(1/2001, Case reports ) - Stroke in diabetic patients
doc. MUDr. Jaromír Chlumský, Ph.D., prof. MUDr. Jindra Perušičová, DrSc., prof. MUDr. Milan Kvapil, CSc.
(1/2010, From the boundary of neurology ) - Léčba diabetické polyneuropatie
MUDr. Helena Vondrová, CSc.
(4/2008, Review articles ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic ) - Epilepsy and metabolic syndrome X
MUDr. Irena Novotná
(3/2011, Review articles )
- Komplex metabolic changes in children with obesity
MUDr. Zlatko Marinov, MUDr. Dalibor Pastucha, Ph.D., MBA
(2/2012, Review articles ) - THE TREATMENT WITH GROWTH HORMONE IN CHILDHOOD
doc. MUDr. Ľudmila Košťálová, CSc.
(4/2008, Review articles ) - Lysosomal storage diseases: current diagnostic and therapeutic options
MUDr. Věra Malinová, doc. MUDr. Tomáš Honzík, Ph.D.
(3/2013, Review articles ) - Risk factors of atherosclerosis in childhood
MUDr. Pavol Šimurka, PhD.
(5/2010, Review articles ) - Homozygous familial hypercholesterolemia and its treatment, cholesterol screening in children in Slovakia
MUDr. Pavol Šimurka, PhD., MUDr. Martin Matejka, PhD., MUDr. Jana Malinová
(2/2016, Review articles ) - The importance of PUFA omega-3 in children
doc. MUDr. Ludmila Vyhnánková, CSc.
(2/2011, Focus ) - Health and psychosocial consequences of obesity in children and adolescents
MUDr. Irena Aldhoon Hainerová, Ph.D., RNDr. Hana Zamrazilová, Ph.D.
(3/2016, Review articles ) - Using probiotics in acute gastroenterocolitis in children. Results of a clinical study
MUDr. Jan Pavelka, MUDr. Lukáš Homola, MUDr. Peter Mikolášek, MUDr. Lenka Krbková, CSc., MUDr. Tomáš Habanec, Ph.D, MUDr. Marta Trnková, Dr. Lenka Čadová
(3/2012, Original articles ) - CRP – Precious advicer in clinical praxis
prof. MUDr. Ľudmila Podracká, CSc.
(4/2009, Review articles ) - LIPIDS IN CHILDHOOD NUTRITION
MUDr. Pavel Frühauf, CSc.
(1/2008, Review articles ) - Vyšetření a sledování dětí s hypercholesterolémií
doc. MUDr. Zuzana Urbanová CSc.
(2/2005, Information & comments ) - Recommendations for diagnosis and treatment of dyslipidaemia in children and adolescents
MUDr. Ľubomíra Fábryová, PhD., MUDr. Anna Hlavatá, PhD.
(S1/2011, Review articles )
- CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles )
- Hormonal aging of skin
MUDr. Radek Litvik
(1/2009, Review articles ) - Impact of life style change to biochemical parameters in psoriasis patients
MUDr. Zuzana Rajczyová, Ing. Pavel Blažíček, CSc., prof. MUDr. Mária Šimaljaková, PhD., MHA
(1/2016, Original articles & case reports )
- NOVÁ DOPORUČENÍ (GUIDELINES) PRO LÉČBU DIABETES MELLITUS 2. TYPU
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2007, clearly ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - Perorální antidiabetika – současnost
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2009, Drugs & drug classes ) - CRP – PRECIOUS ADVICER IN CLINICAL PRAXIS
prof. MUDr. Ľudmila Podracká, CSc.
(4/2008, Review articles ) - METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- New drugs registered in the EU in 2015 (III.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3/2016, New drugs ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Biological effects of Chlorella pyrenoidosa and young barley leaves with possible use in the prevention of civilization diseases
Doc. RNDr. Peter Kubatka, PhD.
(1/2018, Phytotherapy ) - Contribution of the pharmacist in the prevention and treatment of certain risk factors for cardiovascular disease
Mgr. Anita Šestáková
(4/2016, Clinical pharmacy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Medicinal plants in prevention of cardiovascular diseases
PharmDr. Szilvia Czigle, PhD., Mgr. Jaroslav Tóth, PhD.
(1/2014, Phytotherapy ) - Niacin-laropiprant combination: novel approach not only to treatment of dyslipidemia Complex management of dyslipidemia provides a chance of further reduction of atherosclerotic vascular
MUDr. Michal Vrablík, Ph.D., MUDr. Eva Motyková, prof. MUDr. Richard Češka, CSc.
(1/2011, New medicinal substances ) - Modifying cholesterol level with plant substances
PharmDr. Miloš Potužák
(1/2011, Phytotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy ) - Cholesterol z hľadiska životosprávy
PhDr. Marta Martinčeková
(4/2013, For pharmaceutical laboratory technicians ) - Pharmacist´s role in educating a patient with diabetes mellitus – part I
PharmDr. Lucia Masaryková, PhD.,, Doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD.
(1/2017, Clinical pharmacy )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - Pharmacological treatment of peripheral arterial disease of lower limbs from a vascular surgeon’s point of view
prof. MUDr. Vladimír Šefránek, PhD.
(3-4/2012, Review articles ) - Abstrakty
(1/2009, Abstracts ) - Prevention and non-pharmacological treatment of arterial disease
prof. MUDr. Viera Štvrtinová, CSc., doc. MUDr. Ľudovít Gašpar, CSc., prof. MUDr. Andrej Dukát, CSc., FESC, MUDr. Denisa Čelovská, PhD.
(1/2014, Review articles ) - Dekubitus – ako prejav kritickej končatinovej ischémie?
MUDr. Lucia Maheľová, MUDr. Lucia Kukučková, MUDr. Katarína Dostálová, PhD., MPH, doc. MUDr. Štefánia Moricová, PhD., MPH, mim. prof., RNDr. Ján Luha, CSc.
(1/2014, Original articles & Case reports ) - Statíny – benefi t len zo znižovania lipidov?
prof. MUDr. Daniel Pella, PhD.
(3/2011, Editorial ) - High cardiovascular risk in patient with critical limb ischaemia – principles of conservative treatment
MUDr. Peter Gergely
(3/2011, Main topic ) - Treatment of critical limb ischemia with prostaglandin E1
doc. MUDr. Ľudovít Gašpar, CSc., doc. MUDr. Peter Gavorník, PhD., prof. MUDr. Viera Štvrtinová, PhD., MUDr. Denisa Čelovská, PhD., MUDr. Andrea Komorníková, MUDr. Ewald Ambrózy, PhD., MUDr. Matej Bendžala, PhD.
(2/2015, Original articles & Case reports ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes ) - Significance of hematological markers on cardiovascular risk
MUDr. Marek Kučera, PhD., MHA, MPH
(2/2019, Original articles & Case reports ) - Claudicatio intermittens – an important marker of systemic atherosclerosis
prof. MUDr. Viera Štvrtinová, PhD.
(3/2010, Main topic ) - Úvaha nad šálkou čaju
prof. MUDr. Marián Bernadič, CSc.
(2/2013, Editorial ) - Markers of vulnerable plaque in atherosclerotic internal carotid artery affected
MUDr. Mária Kubíková, PhD., MUDr. Pavel Staško, PhD., MUDr. Peter Štefanič, MUDr. Peter Berek, PhD., MUDr. Ivan Kopolovets, MUDr. Jana Pobehová, PhD.
(1/2016, Main topic ) - Vascular risk treatment and blood pressure control in patients with peripheral arterial disease of lower extremity
MUDr. Denisa Čelovská, PhD., MUDr. Zuzana Celecová, MUDr. Kristína Letková, prof. MUDr. Viera Štvrtinová, CSc., doc. MUDr. Ľudovít Gašpar, CSc.
(1/2013, Main topic ) - Complications of endovascular treatment of abdominal aortic aneurysm
MUDr. Ľubomír Špak, MUDr. Mária Rašiová, PhD., MUDr. Ľudmila Farkašová, PhD.
(1/2015, Original articles & Case reports ) - Mediocalcinosis – the marker of high cardiovascular risk
prof. MUDr. Peter Labaš, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Michal Makovník, MUDr. Stella Hlinšťáková, doc. MUDr. Peter Gavorník, PhD., prof. MUDr. Andrej Dukát, CSc., FESC, prof. MUDr. Viera Štvrtinová, PhD., Mgr. Margita Fülleová, MUDr. Svetoslav Štvrtina, PhD.
(1/2011, Original articles & Case reports ) - Identification of periprocedural risks of carotid stenting in selected populations
MUDr. Mária Rašiová, PhD., MUDr. Norbert Leško, MUDr. Ľudmila Farkašová, PhD., MUDr. Ľubomír Špak, MPH, MUDr. Štefan Pataky, MUDr. Martin Koščo, MUDr. Marek Hudák, PhD.
(2/2016, Original articles & Case reports )
- Perioperative management of obese patient
MUDr. Monika Grochová, PhD., MUDr. Štefan Trenkler, PhD., doc. MUDr. Jozef Firment, PhD.
(2/2013, Review articles )